Details of the Drug

General Information of Drug (ID: DMY78E0)

• Drug Name: ADCT-301
• Synonyms: camidanlumab tesirine

Indication

Disease Entry	ICD 11	Status	REF
Hodgkin lymphoma	2B30	Phase 2	[1]
Acute lymphoblastic leukaemia	2A85	Phase 1	[2]
Acute myeloid leukaemia	2A60	Phase 1	[2]
Lymphoma	2A80-2A86	Phase 1	[3]

• Cross-matching ID:
  UNII: LYJ1AEJ9YH
  DrugBank ID: DB16411
  TTD ID: D0LL1N
• Repurposed Drugs (RPD): Click to Jump to the Detailed RPD Information of This Drug

References

• [1] ClinicalTrials.gov (NCT04052997) Study to Evaluate the Efficacy and Safety of Camidanlumab Tesirine (ADCT-301) in Patients With Relapsed or Refractory Hodgkin Lymphoma. U.S. National Institutes of Health.
• [2] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
• [3] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)